The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity

por Dragowska, Wieslawa H, Weppler, Sherry A, Qadir, Mohammed A, Wong, Ling Yan, Franssen, Yannick, Baker, Jennifer HE, Kapanen, Anita I, Kierkels, Guido JJ, Masin, Dana, Minchinton, Andrew I, Gelmon, Karen A, Bally, Marcel B
Publicado 2011

Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells

por Kierkels, Guido J.J., van Diest, Eline, Hernández-López, Patricia, Scheper, Wouter, de Bruin, Anja C.M., Frijlink, Elselien, Aarts-Riemens, Tineke, van Dooremalen, Sanne F.J., Beringer, Dennis X., Oostvogels, Rimke, Kramer, Lovro, Straetemans, Trudy, Uckert, Wolfgang, Sebestyén, Zsolt, Kuball, Jürgen
Publicado 2021